AstraZeneca Pharma India Limited (BSE: 506820)
Health Care · Pharmaceuticals · IN
Rs5,831.85
-3.29% today · -37.1% 1Y
AstraZeneca Pharma India Limited (BSE: 506820) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.51B.
Over the last twelve months the share price has lost 37.1%, trading between 5.66K and 9.85K.
Tweenvest scores AstraZeneca Pharma India Limited across four factors: quality 78/100, value 78/100, growth 96/100, dividend 72/100. Its strongest factor is growth.
506820 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.51B
- Revenue (TTM)
- $257.22M
- P/E
- 85.96
- EPS
- 67.85
- Dividend yield
- 0.62%
- Beta (5Y)
- 0.23
- 52-week high
- Rs9,850.00
- 52-week low
- Rs5,660.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Innoviva, Inc.NasdaqGS: INVA | $1.53B | $21.46 | +1.18% |
| Jubilant Pharmova LimitedBSE: 530019 | $1.52B | Rs931.20 | -6.94% |
| Lotus Pharmaceutical Co., Ltd.TWSE: 1795 | $1.52B | NT$180.50 | +2.56% |
| Caregen Co., Ltd.KOSDAQ: A214370 | $1.52B | ₩41,800.00 | -1.76% |
| Maze Therapeutics, Inc.NasdaqGM: MAZE | $1.51B | $28.39 | +4.72% |
| Yifan Pharmaceutical Co., Ltd.SZSE: 002019 | $1.50B | CN¥9.66 | +2.55% |
| Tianjin Chase Sun Pharmaceutical Co.,LtdSZSE: 300026 | $1.49B | CN¥3.32 | +2.15% |
| Jiangxi Fushine Pharmaceutical Co., Ltd.SZSE: 300497 | $1.48B | CN¥18.43 | +3.19% |
Figures last refreshed Oct 11, 2026.